- Home
- Equipment
- usa georgia
- assessing patient
Refine by
Assessing Patient Equipment Supplied In Usa Georgia
5 equipment items found
Manufactured by:Quantificare Inc. based inSuwanee, GEORGIA (US) (USA)
LifeViz® Body : A portable 3D Imaging System for Body & Breast. The LifeViz® Body is the first portable 3D imaging system capable of capturing 360° body and breast in order to simulate body contouring procedures, breast augmentation and photo-document before/after interventions. The LifeViz® Body is a compact system composed of a 3D camera mounted on a tripod with a turntable ...
Manufactured by:Quantificare Inc. based inSuwanee, GEORGIA (US) (USA)
LifeViz® Mini : A portable, 3D Imaging System for the Face. Awarded Best Aesthetic Device, the LifeViz® Mini is designed to illustrate the face in 3D. Known for its image quality and precision, the 3D photographic system is a portable, compact and user-friendly solution for aesthetic practitioners, dermatologists, cosmetic and plastic surgeons. Reproducible pictures are possible without ...
Manufactured by:Quantificare Inc. based inSuwanee, GEORGIA (US) (USA)
LifeViz® Infinity : All in One System for Face, Body & Breast. The LifeViz® Infinity is a comprehensive 3D solution for face, body and breast procedures. Capture an accurate representation to help patients see themselves in 3D. Open a dialogue with patients and enhance the overall consultation experience. The LifeViz® Infinity is a unique system composed of a 3D camera mounted on ...
Distributed by:Probo Medical based inFishers, INDIANA (USA)
National Ultrasound is proud to carry the high–quality Philips Lumify® which is a mobile app that works with an ultrasound transducer that brings diagnostic capabilities to your compatible smartphone or handheld device. National Ultrasound is also proud to carry a full line of Philips® ultrasound machines. ...
Manufactured by:Clearside Biomedical based inAlpharetta, GEORGIA (US) (USA)
CLS-AX (axitinib injectable suspension) is a proprietary suspension of axitinib for suprachoroidal use. Axitinib is a tyrosine kinase inhibitor (TKI) currently approved to treat renal cell cancer that achieves pan-VEGF blockade, directly inhibiting VEGF receptors-1, -2, and -3 with high potency and specificity. We believe this broad VEGF blockade may have efficacy advantages over existing retinal ...